KORU Medical Systems (KRMD) EBITDA (2010 - 2026)

KORU Medical Systems' EBITDA history runs 12 years deep, the most recent figure standing at -$864923.0 for Q1 2026.

• In Q1 2026, EBITDA rose 30.53% year-over-year to -$864923.0; the TTM figure through Mar 2026 stood at $929449.0 (up 117.59% YoY), while the FY2025 annual figure was $549368.0, up 108.52% from the prior year.
• EBITDA was -$864923.0 for Q1 2026 at KORU Medical Systems, down from $3.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $3.0 million in Q4 2025 to a low of -$3.5 million in Q2 2022.
• Historically, EBITDA has averaged -$1.5 million across 5 years, with a median of -$1.6 million in 2024.
• The sharpest annual moves came in 2022 and 2025: EBITDA plunged 173.57% in 2022, then soared 287.14% in 2025.
• A 5-year view of EBITDA shows it stood at -$2.5 million in 2022, then increased by 12.5% to -$2.2 million in 2023, then increased by 27.67% to -$1.6 million in 2024, then jumped by 287.14% to $3.0 million in 2025, then sank by 129.08% to -$864923.0 in 2026.
• The last three EBITDA figures came in at -$864923.0 (Q1 2026), $3.0 million (Q4 2025), and -$867679.0 (Q3 2025), per Business Quant data.